跳至主要内容
临床试验/ITMCTR2022000098
ITMCTR2022000098招募中1 期

Efficacy evaluation and mechanism study of Yiqi Huashi and Jiedu Tongluo methods in chronic liver disease

Guang'anmen Hospital, China Academy of Chinese Medical Sciences0 个研究点开始时间: 待定最近更新:

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 65(—)
性别
All

入选标准

  • 1. Meet the diagnostic criteria of non-alcoholic fatty liver disease;
  • 2. Meet the diagnostic criteria of Tanzhuo Neizu;
  • 3. Between the ages of 18 and 65, regardless of gender;
  • 4. Willing to participate in the research and sign the informed consent.

排除标准

  • 1. Patients with hepatitis B, C and other liver diseases;
  • 2. Patients with alcoholic liver disease, autoimmune liver disease, drug liver disease, toxic hepatitis, hepatic malignant tumor, occult hepatitis, liver disease of unknown cause;
  • 3. Pregnant or lactation women, allergic constitution;
  • 4. Patients with mental abnormalities who cannot cooperate with this study;
  • 5. Patients complicated with serious diseases of the heart, brain, lung, kidney, hematopoietic and immune systems;
  • 6. Other conditions considered unsuitable for inclusion by the researcher.

研究者

相似试验